← back to search

Yueqi Wang

Memorial Sloan Kettering Cancer Center · US
Area of research
Surgery · Pulmonary and Respiratory Medicine
Research interest
Research interests include Cholangiocarcinoma and Gallbladder Cancer Studies, Gallbladder and Bile Duct Disorders, Pancreatic and Hepatic Oncology Research, and Cancer-related molecular mechanisms research.
h-index
19
citations
1,513
works
94
NIH funding
primary concept
email

Recent publications

Prediction of Non-Transplantable Recurrence After Liver Resection for Solitary Hepatocellular Carcinoma
Journal of Hepatocellular Carcinoma 2024cited by 4position: middledoi
Qingda Granule Attenuates Hypertension-Induced Cardiac Damage via Regulating Renin-Angiotensin System Pathway
Chinese Journal of Integrative Medicine 2024cited by 4position: middledoi
Development and characterisation of [18F]TTDP, a novel T cell immunoglobulin and ITIM domain tracer, in humanised mice and non-human primates
European Journal of Nuclear Medicine and Molecular Imaging 2024cited by 2position: middledoi
Clinical-Radiological Characteristic for Predicting Ultra-Early Recurrence After Liver Resection in Solitary Hepatocellular Carcinoma Patients
Journal of Hepatocellular Carcinoma 2023cited by 6position: middledoi
Diversity and intratumoral heterogeneity in human gallbladder cancer progression revealed by single‐cell RNA sequencing
Clinical and Translational Medicine 2021cited by 99position: middledoi
Serum exosomal hsa-miR-135b-5p serves as a potential diagnostic biomarker in steroid-induced osteonecrosis of femoral head.
PubMed 2020cited by 18position: middle
Genomic <i>ERBB2</i> / <i>ERBB3</i> mutations promote PD-L1-mediated immune escape in gallbladder cancer: a whole-exome sequencing analysis
Gut 2018cited by 200position: middledoi
Tumor‐infiltrating neutrophils predict prognosis and adjuvant chemotherapeutic benefit in patients with biliary cancer
Cancer Science 2018cited by 46position: lastdoi
Long non-coding RNA CRNDE promotes gallbladder carcinoma carcinogenesis and as a scaffold of DMBT1 and C-IAP1 complexes to activating PI3K-AKT pathway
Oncotarget 2016cited by 98position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Sheng Shen · Sun Yat-sen University2 papers (2016–2018)Yanyan Yu · Nanchang University2 papers (2023–2024)Xiaobo Bo · Zhongshan Hospital2 papers (2018–2021)Yuqing Tao · Harbin Medical University2 papers (2023–2024)Houbao Liu · Fudan University2 papers (2018–2021)Yang Zhou · Guangzhou University of Chinese Medicine2 papers (2023–2024)Han Liu · Tulane University1 papers (2016–2016)Mengyuan Zhu · Sun Yat-sen University Cancer Center1 papers (2024–2024)Delong Chen · Guangzhou University of Chinese Medicine1 papers (2020–2020)Zhaoguo Han · Harbin Medical University1 papers (2024–2024)Keji Chen · Macau University of Science and Technology1 papers (2024–2024)Changcheng Wang · Yantai University1 papers (2021–2021)Houbao Liu · Fudan University1 papers (2016–2016)Xiaoling Ni · Fudan University1 papers (2018–2018)Tao Suo · Henan University1 papers (2018–2018)Jingquan Li · Jiangxi Agricultural University1 papers (2021–2021)Hongbin Wang · Kunming University of Science and Technology1 papers (2024–2024) · 1 papers (2024–2024)Hong Yu · The First Affiliated Hospital, Sun Yat-sen University1 papers (2024–2024)Yebo Shao · Sun Yat-sen University1 papers (2016–2016)